Novartis (NVS) Financial Ratios: P/E, ROE & More

Novartis (NVS) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Novartis had a P/E ratio of 18.96 (up from 16.39), return on equity of 30.8% (up from 26.3%), debt-to-equity of 0.76 (up from 0.71) and a current ratio of 1.12 (up from 1.03). A current ratio of 1.12 means current assets exceed current liabilities. Its dividend yield was 3.36% with a payout ratio of 55.9%.

Novartis Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	18.96	16.39	13.95	27.96	8.20	26.64
P/S Ratio	4.68	3.78	4.44	4.47	4.48	4.31
P/B Ratio	5.70	4.43	4.43	3.27	2.90	3.79
Price/Tangible Book	-	-	-	-	21.01	-
Price/FCF	15.07	12.04	15.46	14.60	14.07	17.38
Price/OCF	13.85	11.11	14.33	13.66	13.07	15.75
Enterprise Value Ratios
EV/Revenue	5.08	4.12	4.73	4.71	5.09	4.88
EV/EBITDA	12.27	10.30	12.15	14.68	14.33	16.32
EV/EBIT	15.16	13.04	21.57	22.21	20.43	24.00
EV/FCF	16.37	13.10	16.47	15.36	15.99	19.69
Profitability & Returns
Return on Equity (ROE)	30.81%	26.28%	16.15%	9.51%	36.80%	14.39%
Return on Assets (ROA)	11.14%	10.09%	5.88%	4.62%	5.28%	5.16%
Return on Invested Capital (ROIC)	24.48%	23.55%	15.05%	11.14%	13.29%	7.07%
Return on Capital Employed (ROCE)	22.70%	22.20%	13.90%	10.40%	10.80%	10.70%
Leverage & Solvency Ratios
Debt/Equity	0.76	0.71	0.57	0.47	0.46	0.67
Debt/EBITDA	1.49	1.50	1.44	1.97	1.95	2.49
Debt/FCF	2.02	1.93	1.97	2.10	2.22	3.08
Liquidity Ratios
Current Ratio	1.12	1.03	1.16	1.29	1.51	0.90
Quick Ratio	0.82	0.78	0.88	0.99	1.25	0.65
Efficiency Ratios
Asset Turnover	0.53	0.51	0.43	0.35	0.34	0.41
Inventory Turnover	2.27	2.20	1.91	1.67	1.65	2.31
Yield & Distribution Ratios
Earnings Yield	5.27%	6.10%	7.17%	3.58%	12.19%	3.75%
FCF Yield	6.64%	8.31%	6.47%	6.85%	7.11%	5.76%
Dividend Yield	3.36%	3.90%	3.87%	3.77%	3.86%	4.30%
Payout Ratio	55.91%	63.85%	48.86%	107.92%	30.67%	86.56%
Buyback Yield	3.93%	2.73%	4.78%	2.79%	1.57%	0.99%
Total Return	7.29%	6.62%	8.65%	6.56%	5.43%	5.29%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Novartis Financial Ratios

What is Novartis's P/E ratio?

Novartis's P/E ratio was 18.96 for fiscal 2025 (period ended Dec 31, 2025). It was 16.39 a year earlier.

What is Novartis's return on equity?

Novartis's return on equity (ROE) was 30.8% for fiscal 2025 (period ended Dec 31, 2025). It was 26.3% a year earlier.

What is Novartis's debt-to-equity ratio?

Novartis's debt-to-equity ratio was 0.76 for fiscal 2025 (period ended Dec 31, 2025). It was 0.71 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition